Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RGS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LAPTM4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBS12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADH5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HADH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCSK1N - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELOVL6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABGAP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLNA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on